4113 — Taoka Chemical Co Income Statement
0.000.00%
- ¥15bn
- ¥16bn
- ¥29bn
- 96
- 74
- 94
- 99
Annual income statement for Taoka Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 25,672 | 32,057 | 32,374 | 30,167 | 28,544 |
Cost of Revenue | |||||
Gross Profit | 5,669 | 7,217 | 6,321 | 4,000 | 4,578 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 22,998 | 28,444 | 29,696 | 29,721 | 27,483 |
Operating Profit | 2,673 | 3,614 | 2,678 | 445 | 1,061 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,695 | 3,663 | 2,769 | 478 | 1,128 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,897 | 2,615 | 2,064 | 311 | 820 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,897 | 2,615 | 2,064 | 311 | 820 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,897 | 2,615 | 2,064 | 311 | 820 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 133 | 203 | 146 | 22 | 58 |
Dividends per Share |